New research reveals that NAD+ supplements may slow aging and boost cellular health, but experts urge caution and more ...
About one-third of all drugs approved by the Food and Drug Administration target the largest family of cell membrane ...
Domain Therapeutics Doses First Patients in Phase I/II Trial of DT-7012 Targeting CCR8 in Solid Tumors · DT-7012 is a proprietary, differentiated Treg-depleting anti-CCR8 monoclonal ...
News Medical on MSN
Cyclana Bio Raises £5M to Advance Drug Discovery for Endometriosis
Co-led by NfX and Eka VC, investors include Cocoa VC, Wilbe, and Angel investorsInvestment will support development of whole tissue-based platform for identification of druggable targets and scaling ...
UK biotech Cyclana Bio has secured £5 million ($6.1 million) in pre-seed funding to advance its platform targeting women’s ...
About one-third of all drugs approved by the Food and Drug Administration target the largest family of cell membrane receptors called G ...
Novel targeted therapies for ARID1A-mutant and CDA-resistant cancers highlighted MENLO PARK, CA / ACCESS Newswire / October 27, 2025 / Edison Oncology, a clinical-stage biopharmaceutical company ...
Natural Field Advances Co-Loading Liposome Technology To Boost Health Support Efficacy. During R&D, Natural Field focused on co-loading CoQ10 liposomes and co-loading curcumin liposomes for efficacy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback